Literature DB >> 1081878

Some biological properties of flurbiprofen, an anti-inflammatory, analgesic and antipyretic agent.

S S Adams, K F McCullough, J S Nicholson.   

Abstract

2-(2-Fluoro-4-biphenyl)propionic acid (flurbiprofen) possesses peripheral analgesic, anti-inflammatory and antipyretic properties. It does not possess glucocorticoid or adrenocortical-stimulating properties. It is a highly potent agent which in acute pharmacological test systems produced a significant pharmacological effect in single oral doses varying from 0.04 to 0.47 mg/kg. The peak plasma concentrations attained after these doses were generally of the order of 1 to 3 mug/ml. Doses of 0.33 mg/kg/day, which gave peak plasma concentrations of 0.6 mug/ml, produced a significant inhibition of rat adjuvant arthritis, both developing and established. The very shallow dose-response curves for flurbiprofen compared with acetylsalicylic acid, especially in the mouse and the rat test systems, are not due to an unreliable or abnormal absorption, which suggests that in these species the mode of action of flurbiprofen is not identical with that of acetylsalicylic acid.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081878

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

Review 1.  The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia.

Authors:  B Dubinsky; S Gebre-Mariam; R J Capetola; M E Rosenthale
Journal:  Agents Actions       Date:  1987-02

2.  Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition.

Authors:  K Brune; W S Beck; G Geisslinger; S Menzel-Soglowek; B M Peskar; B A Peskar
Journal:  Experientia       Date:  1991-03-15

3.  Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats.

Authors:  A Mukherjee; V G Hale; O Borga; R Stein
Journal:  Inflamm Res       Date:  1996-11       Impact factor: 4.575

4.  The effect oa a new anti-inflammatory drug, flurbiprofen, on the respiratory, haemodynamic and metabolic responses to E. coli endotoxin shock in the cat.

Authors:  J R Parratt; R M Sturgess
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

5.  The relationship between development of ultraviolet erythema and release of prostaglandins in guinea pig skin.

Authors:  S S Adams; R G Humphries; C G Mason
Journal:  Agents Actions       Date:  1981-11

Review 6.  Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

7.  A comparison of the carrageenan edema test and ultraviolet light-induced erythema test as predictors of the clinical dose in rheumatoid arthritis.

Authors:  I G Otterness; E H Wiseman; D J Gans
Journal:  Agents Actions       Date:  1979-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.